4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001562180-19-003930
Chief Executive Officer sold 16,969 shares at an average $213.12 ($3,616,428)
- Chief Executive Officer acquired 16,969 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2019-07-10 | Option exercise | +16,969 | $67.46 | $1,144,729 | 109,145 | D |
| Kummeth Charles R. Chief Executive Officer | 2019-07-10 | Sale | −6,566 | $212.75 | $1,396,911 | 102,579 | D |
| Kummeth Charles R. Chief Executive Officer | 2019-07-10 | Sale | −9,909 | $213.32 | $2,113,768 | 92,670 | D |
| Kummeth Charles R. Chief Executive Officer | 2019-07-10 | Sale | −494 | $214.07 | $105,750 | 92,176 | D |
| Derivatives | |||||||
| Kummeth Charles R. Chief Executive Officer | 2019-07-10 | Option exercise · Stock Options (Right to buy) | −16,969 | 0 | D | ||
| Open-market sales · 16,969 sh · avg $213.12 · $3,616,428 | |||||||
Loading xslF345X03/primarydocument.xml…